Literature DB >> 20031375

In vitro interference of beta-lactams with biofilm development by prevalent community respiratory tract isolates.

J R Maestre1, M Mateo, M L Méndez, L Aguilar, M J Gimenez, L Alou, P Coronel, J J Granizo, J Prieto.   

Abstract

Interference of cefditoren (CDN) and amoxicillin/clavulanic acid (AMC) with biofilm production was studied using 11 Streptococcus pneumoniae isolates with minimum inhibitory concentrations (MICs) ranging from 0.015microg/mL to 0.5microg/mL for CDN and from 0.06microg/mL to 2microg/mL for AMC (except for one isolate with an AMC MIC of 8microg/mL) and 5 Haemophilus influenzae isolates with MICs of 0.03-0.06microg/mL for CDN and 0.5-16microg/mL for AMC. Slime production was assessed in antibiotic-free medium and with 0.03microg/mL CDN or 1/0.5microg/mL AMC by measuring the optical density at 450nm (OD(450)). Significantly lower mean OD(450) values were obtained for S. pneumoniae with antibiotics compared with controls (CDN, 0.088 vs. 0.118, P=0.003; and AMC, 0.095 vs. 0.112, P=0.003), with significant correlation between both antibiotics (r=0.752; P=0.008). Percent reduction in OD(450) values was higher for CDN compared with AMC (24.02% vs. 15.92%; P=0.008). For H. influenzae, significantly lower mean OD(450) values were obtained with CDN compared with controls (0.083 vs. 0.096; P=0.043) but not with AMC (0.086 vs. 0.095; P=0.08). Comparing percent reductions in S. pneumoniae versus H. influenzae for each antibiotic, no differences were found for AMC (15.92% vs. 9.40%; P=0.36), with a tendency for CDN (24.02% vs. 13.79%; P=0.069). Different beta-lactams may have different capabilities of interfering with S. pneumoniae biofilm development when tested under the same experimental conditions. Copyright 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20031375     DOI: 10.1016/j.ijantimicag.2009.10.020

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

1.  Antibiofilm effects of amoxicillin-clavulanic acid and levofloxacin in patients with chronic rhinosinusitis with nasal polyposis.

Authors:  Dragana D Božić; Bojan Pavlović; Jovica Milovanović; Ana Jotić; Jelena Čolović; Ivana Ćirković
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-29       Impact factor: 2.503

2.  In Vitro Efficacy of Nonantibiotic Treatments on Biofilm Disruption of Gram-Negative Pathogens and an In Vivo Model of Infectious Endometritis Utilizing Isolates from the Equine Uterus.

Authors:  Ryan A Ferris; Patrick M McCue; Grace I Borlee; Kristen D Loncar; Margo L Hennet; Bradley R Borlee
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

Review 3.  Biofilm formation in Streptococcus pneumoniae.

Authors:  Mirian Domenech; Ernesto García; Miriam Moscoso
Journal:  Microb Biotechnol       Date:  2011-09-09       Impact factor: 5.813

Review 4.  Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.

Authors:  María-José Giménez; Lorenzo Aguilar; Juan José Granizo
Journal:  Multidiscip Respir Med       Date:  2018-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.